Manufacturers Life Insurance Company, The Cyclerion Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$2.25 - $7.12 $31,898 - $100,940	-14,177 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$2.37 - $7.14 $703 - $2,120	297 Added 2.14%	14,177 $84,000
Q1 2020 May 15, 2020	BUY	$2.46 - $5.84 $34,144 - $81,059	13,880 New	13,880 $37,000
Q4 2019 Feb 14, 2020	SELL	$1.8 - $13.43 $29,358 - $219,043	-16,310 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$8.12 - $14.54 $4,912 - $8,796	605 Added 3.85%	16,310 $216,000
Q2 2019 Aug 14, 2019	BUY	$9.6 - $22.85 $150,768 - $358,859	15,705 New	15,705 $180,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $78.3M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.